Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Stromal Tumors

Explore clinical trials studying Gastrointestinal Stromal Tumors. Study availability and eligibility vary by location and protocol.

244 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Stromal Tumors trial results

Completed

A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)

NCT04282980

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chinese People's Liberation Army General Hospital Beijing, Beijing Municipality, China
  • Union Medical College Hospital, Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Union Medical College Hospital, Fujian Medical University Fuzhou, Fujian, China
View Trial Details
Completed

CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors

NCT02401815

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Sylvester Comprehensive Cancer Center/ UMHC Miami, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

A Drug-drug Interaction Study of Avapritinib and Midazolam

NCT04908176

Conditions
Astrocytoma, Digestive System Diseases, Digestive System Neoplasms, +21 more
Locations
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.

NCT03345485

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +50 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • New York University New York, United States
View all 13 locations
View Trial Details
Completed

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

NCT04530981

Conditions
Digestive System Diseases, Digestive System Neoplasms, GIST - Gastrointestinal Stromal Tumor, +7 more
Locations
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Completed

Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment

NCT01863745

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Kashiwa, Chiba, Japan
  • Novartis Investigative Site Gifu, Japan
  • Novartis Investigative Site Sapporo, Hokkaido, Japan
View Trial Details

Related conditions